Galectin-3 induces a pro-degradative/inflammatory gene signature in human chondrocytes, teaming up with galectin-1 in osteoarthritis pathogenesis

Scientific Reports

Volumn 6, Issue 1, 2016, Pages

  Weinmann, Daniela ^a   Schlangen, Karin ^a   André, Sabine ^b   Schmidt, Sebastian ^b   Walzer, Sonja M ^a   Kubista, Bernd ^a   Windhager, Reinhard ^a   Toegel, Stefan ^a   Gabius, Hans Joachim ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; GALECTIN 3; GALECTIN-3, HUMAN; LGALS1 PROTEIN, HUMAN;

AGED; CHONDROCYTE; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHONDROCYTES; EXTRACELLULAR MATRIX; FEMALE; GALECTIN 1; GALECTIN 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 85019157750     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39112     Document Type: Article

References (60)

1. Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376-387 (2015).
2. Roos, E. M. & Arden, N. K. Strategies for the prevention of knee osteoarthritis. Nat. Rev. Rheumatol. 12, 92-101 (2016).
3. Hirabayashi, J. Recent topics on galectins. Trends Glycosci. Glyc. 9, 1-180 (1997).
4. Kaltner, H. & Gabius, H.-J. A toolbox of lectins for translating the sugar code: the galectin network in phylogenesis and tumors. Histol. Histopathol. 27, 397-416 (2012).
5. Liu, F.-T., Yang, R.-Y. & Hsu, D. K. Galectins in acute and chronic inflammation. Ann. N.Y. Acad. Sci. 1253, 80-91 (2012).
6. Goldstone, S. D. & Lavin, M. F. Isolation of a cDNA clone, encoding a human β -galactoside binding protein, overexpressed during glucocorticoid-induced cell death. Biochem. Biophys. Res. Commun. 178, 746-750 (1991).
7. INK4a: anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. FEBS J. 279, 4062-4080 (2012).
8. Rabinovich, G. A. et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190, 385-398 (1999).
9. Wang, C.-R. et al. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collageninduced arthritis. Gene Ther. 17, 1225-1233 (2010).
10. Forsman, H. et al. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum. 63, 445-454 (2011).
11. Iqbal, A. J. et al. Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. J. Immunol. 191, 171-177 (2013).
12. Li, S., Yu, Y., Koehn, C. D., Zhang, Z. & Su, K. Galectins in the pathogenesis of rheumatoid arthritis. J. Clin. Cell. Immunol. 4, 1000164 (2013).
13. Toegel, S. et al. Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein. Arthritis Res. Ther. 15, R147 (2013).
14. Toegel, S. et al. Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration. Histochem. Cell Biol. 142, 373-388 (2014).
15. Toegel, S. et al. Galectin-1 couples glycobiology to inflammation in osteoarthritis through the activation of an NF-κ B-regulated gene network. J. Immunol. 196, 1910-1921 (2016).
16. Gabius, H. J., Manning, J. C., Kopitz, J., Andre, S. & Kaltner, H. Sweet complementarity: the functional pairing of glycans with lectins. Cell. Mol. Life Sci. 73, 1989-2016 (2016).
17. Osorio, J. Osteoarthritis: Galectin-1 damages cartilage via inflammation. Nat. Rev. Rheumatol. 12, 132 (2016).
18. Ippel, H. et al. Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR. Glycobiology., doi: 10.1093/glycob/cww021 (2016).
19. Reesink, H. L. et al. Galectin-3 binds to lubricin and reinforces the lubricating boundary layer of articular cartilage. Sci. Rep. 6, 25463 (2016).
20. Ohshima, S. et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48, 2788-2795 (2003).
21. Colnot, C., Sidhu, S. S., Poirier, F. & Balmain, N. Cellular and subcellular distribution of galectin-3 in the epiphyseal cartilage and bone of fetal and neonatal mice. Cell. Mol. Biol. 45, 1191-1202 (1999).
22. Colnot, C., Sidhu, S. S., Balmain, N. & Poirier, F. Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones. Dev. Biol. 229, 203-214 (2001).
23. Guevremont, M. et al. Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3. Ann. Rheum. Dis. 63, 636-643 (2004).
24. Janelle-Montcalm, A. et al. Extracellular localization of galectin-3 has a deleterious role in joint tissues. Arthritis Res. Ther. 9, R20 (2007).
25. Arad, U. et al. Galectin-3 is a sensor-regulator of Toll-like receptor pathways in synovial fibroblasts. Cytokine 73, 30-35 (2015).
26. Burguillos, M. A. et al. Microglia-secreted Galectin-3 acts as a Toll-like receptor 4 ligand and contributes to microglial activation. Cell Reports 10, 1626-1638 (2015).
27. Jouault, T. et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol. 177, 4679-4687 (2006).
28. He, J. & Baum, L. G. Presentation of galectin-1 by extracellular matrix triggers T cell death. J. Biol. Chem. 279, 4705-4712 (2004).
29. Yang, R. Y., Hsu, D. K. & Liu, F.-T. Expression of galectin-3 modulates T-cell growth and apoptosis. P. Natl. Acad. Sci. USA 93, 6737-6742 (1996).
30. Liu, F.-T., Patterson, R. J. & Wang, J. L. Intracellular functions of galectins. Biochim. Biophys. Acta 1572, 263-273 (2002).
31. Harazono, Y. et al. Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells. Oncotarget 5, 9992-10001 (2014).
32. Krzeminski, M. et al. Human galectin-3 (Mac-2 antigen): defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region. Biochim. Biophys. Acta 1810, 150-161 (2011).
33. Dawson, H., Andre, S., Karamitopoulou, E., Zlobec, I. & Gabius, H.-J. The growing galectin network in colon cancer and clinical relevance of cytoplasmic galectin-3 reactivity. Anticancer Res. 33, 3053-3059 (2013).
34. Boileau, C. et al. Intracellular localisation of galectin-3 has a protective role in chondrocyte survival. Ann. Rheum. Dis. 67, 175-181 (2008).
35. Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648 (2005).
36. Tian, Y. et al. TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: implications in intervertebral disc degeneration. Matrix Biol. 50, 39-52 (2016).
37. Scher, J. U., Pillinger, M. H. & Abramson, S. B. Nitric oxide synthases and osteoarthritis. Curr. Rheumatol. Rep. 9, 9-15 (2007).
38. van de Wouwer, M., Andre, S., Gabius, H.-J. & Villalobo, A. Nitric oxide changes distinct aspects of the glycophenotype of human neuroblastoma NB69 cells. Nitric Oxide 24, 91-101 (2011).
39. Rasheed, Z., Al-Shobaili, H. A., Rasheed, N., Mahmood, A. & Khan, M. I. MicroRNA-26a-5p regulates the expression of inducible nitric oxide synthase via activation of NF-κ B pathway in human osteoarthritis chondrocytes. Arch. Biochem. Biophys. 594, 61-67 (2016).
40. Walker, J. T., Elliott, C. G., Forbes, T. L. & Hamilton, D. W. Genetic deletion of Galectin-3 does not impair full-thickness excisional skin healing. J. Invest. Dermatol. 136, 1042-1050 (2016).
41. Kadrofske, M. M., Openo, K. P. & Wang, J. L. The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch. Biochem. Biophys. 349, 7-20 (1998).
42. Fei, F. et al. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget 6, 11378-11394 (2015).
43. Lu, H. et al. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κ B pathway. Tumor Biol., doi: 10.1007/s13277-016-5004-3 (2016).
44. Filer, A. et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum. 60, 1604-1614 (2009).
45. Kopitz, J. et al. Human chimera-type galectin-3: defining the critical tail length for high-affinity glycoprotein/cell surface binding and functional competition with galectin-1 in neuroblastoma cell growth regulation. Biochimie 104, 90-99 (2014).
46. Kopitz, J. et al. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J. Biol. Chem. 276, 35917-35923 (2001).
47. INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 277, 3552-3563 (2010).
48. Gabius, H.-J., Kaltner, H., Kopitz, J. & Andre, S. The glycobiology of the CD system: a dictionary for translating marker designations into glycan/lectin structure and function. Trends Biochem. Sci. 40, 360-376 (2015).
49. Pabst, M. et al. IL-1β and TNF-α alter the glycophenotype of primary human chondrocytes in vitro. Carbohydr. Res. 345, 1389-1393 (2010).
50. Toegel, S. et al. Phenotype-related differential α -2,6- or α -2,3-sialylation of glycoprotein N-glycans in human chondrocytes. Osteoarthr. Cartilage 18, 240-248 (2010).
51. Matarrese, P. et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85, 545-554 (2000).
52. Garcia Caballero, G. et al. Galectin-related protein: An integral member of the network of chicken galectins 1. From strong sequence conservation of the gene confined to vertebrates to biochemical characteristics of the chicken protein and its crystal structure. Biochim. Biophys. Acta., doi: 10.1016/j.bbagen.2016.06.001 (2016).
53. Chang, Y.-C. et al. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLoS Pathog. 10, e1003846 (2014).
54. Bartoloni, M. et al. Targeting matrix metalloproteinases: design of a bifunctional inhibitor for presentation by tumour-associated galectins. Chemistry 19, 1896-1902 (2013).
55. Andre, S., Kaltner, H., Kayser, K., Murphy, P. V. & Gabius, H.-J. Merging carbohydrate chemistry with lectin histochemistry to study inhibition of lectin binding by glycoclusters in the natural tissue context. Histochem. Cell Biol. 145, 185-199 (2016).
56. Sarter, K. et al. Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins. Biochem. Biophys. Res. Commun. 379, 155-159 (2009).
57. Kaltner, H. et al. Network monitoring of adhesion/growth-regulatory galectins: localization of the five canonical chicken proteins in embryonic and maturing bone and cartilage and their introduction as histochemical tools. Anat. Rec. 298, 2051-2070 (2015).
58. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. P. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
59. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
60. Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G. D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5, e13984 (2010).